Regeneron co-founders George Yancopoulos (L) and Leonard Schleifer (Lev Radin/Pacific Press/LightRocket via Getty Images)
Regeneron will start delivering quarterly dividends 37 years into its existence
Regeneron Pharmaceuticals, one of the original and longest-standing biotech companies, is entering the dividends arena for the first time.
The Tarrytown, NY-based drugmaker surprised the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.